Be a Smart Investor
Friday, April 7, 2017
Company Spotlight: Akari Therapeutics
Akari Therapeutics PLC (AKTX) has returned an impressive 107% so far this year compared to a modest 8.60% rise in the iShares NASDAQ Biotech Index ETF (IBB) during the same period.
from RTT - Biotech http://ift.tt/2oQ1fnb
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment